Proline analogue of melphalan as a prodrug susceptible to the action of prolidase in breast cancer MDA-MB 231 cells

Farmaco

Volumn 58, Issue 11, 2003, Pages 1113-1119

  Chrzanowski, Krzysztof ^a   Bielawska, Anna ^a   Pałka, Jerzy ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Breast cancer cells; Collagen; Prodrug; Prolidase; Proline analogue of melphalan

Indexed keywords

MELPHALAN; PRODRUG; PROLINE DERIVATIVE; PROLINE DIPEPTIDASE;

ARTICLE; BREAST CANCER; CANCER CELL; CELL TRANSPORT; COLLAGEN SYNTHESIS; CYTOSOL; CYTOTOXICITY; DNA SYNTHESIS; DRUG CONJUGATION; DRUG EFFECT; DRUG MECHANISM; DRUG SYNTHESIS; DRUG TRANSPORT; ENZYME ACTIVITY; ENZYME SUBSTRATE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

EID: 0142155711     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(03)00164-2     Document Type: Article

References (25)

1. Farmer P.B. Metabolism and reactions of alkylating agents. Pharmacol. Therap. 35:1987;301-358.
2. Takakura Y., Takagi A., Hashida M., Sezeki H. Disposition and tumor localization of mitomycin C-dextran conjugates in mice. Pharm. Res. 4:1987;293-300.
3. Takahara Y., Atsumi R., Hashida M., Sezeki H. Development of a novel polymeric prodrug of mitomycin C-dextran conjugate with anionic charge. II. Disposition and pharmacokinetics following intravenous and intramuscular administration. Int. J. Pharm. 7:1987;145-152.
4. Bai J.P.-F., Hu M., Subramanian P., Mosberg H.I., Amidon G.L. Utilization of peptide carrier system to improve intestinal absorption: targeting prolidase as a prodrug-converting enzyme. J. Pharm. Sci. 2:1992;113-116.
5. Bielawska A., Bielawski K., Palka J. Prolidase as a prodrug converting enzyme. III. Synthesis of proline analogue of melphalan and their susceptibility to the action of prolidase. Ann. Acad. Med. Bialostocensis. 44:1999;190-199.
6. Bielawska A., Bielawski K. Synthesis of proline analogue of antineoplastic compounds as prodrugs for activation by prolidase. Acta Pol. Pharm. 56:1999;39-41.
7. Endo F., Tanoue A., Nakai H., Hata A., Indo Y., Titani K., Matsuda I. Primary structure and gene localization of human prolidase. J. Biol. Chem. 264:1989;4476-4481.
8. Phang J., Scriver C. Disorders of proline and hydroxyproline metabolism. Scriver C.R., Beaudet A.L., Sly W.S., Valle D. The Metabolic Basis of Inherited Disease. 1989;577-597 McGraw Hill, New York.
9. Jackson S., Dennis A., Greenberg M. Iminopeptiduria. A genetic defect in recycling collagen: a method for determining prolidase in red blood cells. Can. Med. Assoc. J. 113:1975;759-763.
10. 1 integrin expression in moderately and poorly differentiated lung adenocarcinomas. Ann. Acad. Med. Bialostocensis. 42:1997;241-250.
11. Oyamada I., Palka J., Schalk E.M., Takeda K., Peterkofsky B. Scorbutic and fasted guinea pig sera contain an insulin-like growth factor-I reversible inhibitor of proteoglycan and collagen synthesis in chick embryo chondrocytes and adult human skin fibroblasts. Arch. Biochem. Biophys. 276:1990;85-93.
12. Peterkofsky B., Chojkier M., Bateman J. Determination of collagen synthesis in tissue and cell culture system. Futhmay M. Immunochemistry of the Extracellular Matrix. 1982;19-47 CRP, Boca Raton, FL.
13. Myara I., Charpentier C., Lemonnier A. Optimal conditions for prolidase assay by proline colorimetric determination: application to imidodipeptiduria. Clin. Chim. Acta. 125:1982;193-205.
14. Chinard F.P. Photometric estimation of proline and ornithine. J. Biol. Chem. 199:1952;91-95.
15. Lowry I., Rosenbergh N., Farr A., Randall I. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
16. Carmichael J., Degraff W., Gazdar A., Minna J., Mitchell J. Evaluation of a tetrazolinum-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res. 47:1987;936-942.
17. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
18. Miltyk W., Karna E., Palka J. Inhibition of prolidase activity by non-steroid antiinflammatory drugs in cultured human skin fibroblasts. Pol. J. Pharmacol. 48:1996;609-613.
19. Goldstein R.H., Poliks C.F., Pilch P.F., Smith B.D., Fine A. Stimulation of collagen formation by insulin and insulin-like growth factor-I in cultures of human lung fibroblasts. Endocrinology. 124:1989;964-997.
20. Palka J., Bird T.A., Oyamada I., Peterkofsky B. Similar hormonal changes in sera from scorbutic and fasted (vitamin C-supplemented) guinea pigs, including decreased IGF-I and appearance of an IGF-I reversible mitogenic inhibitor. Growth Factors. 1:1989;147-156.
21. Chang L., Karin M. Mammalian MAP kinase signalling cascades. Nature. 410:2001;37-40.
22. Hill C.S., Treisman R. Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell. 80:1995;199-211.
23. Hill B.T. Studies on the transport and cellular distribution of chlorambucil in the Yoshida ascites sarcoma. Biochem. Pharmacol. 21:1972;495-502.
24. Begleiter A., Goldenberg G.J. Uptake and decomposition of chlorambucil by L5178Y lymphoblasts in vitro. Biochem. Pharmacol. 32:1983;535-539.
25. Karna E., Surarzynski A., Palka J. Collagen metabolism disturbances are accompanied by an increase in prolidase activity in lung carcinoma planoepitheliale. Int. J. Exp. Path. 81:2000;1-8.